InvestorsHub Logo
Followers 14
Posts 1782
Boards Moderated 0
Alias Born 05/26/2010

Re: Risk post# 980

Tuesday, 12/11/2012 8:35:07 PM

Tuesday, December 11, 2012 8:35:07 PM

Post# of 1276
Risk,

I think what folks are missing is what is in the previous 10k financial filings. Convertible notes were used to fund the company from 2010 to current. Until conversion of notes and/or exercise of warrants, they do not count towards the float or issued outstanding share counts. They would show under derivative liabilities or a SS count including fully diluted issued and outstanding shares, warrants and options. Some may be restricted which would not impact the float. It is possible that some of these obligations are being met and dealt with through the RS, allowing the company to maintain an adequate share structure to attain necessary funding for development of Rev 1.

Development of Rev 1 has always been the target and funding was always the key, this has not changed and has always been above board. Remember Crucible and Moody Capital, both investment banks failed to deliver adequate funding during an absolute horrendous time to raise funds.

It is either fund and develop (which equals dilution) or BK. At what cost should Brook stop trying to develop the product? If the only deal he had was at .0001 would that be bad? Yes, it would be bad but BK would be worse.

My point is that there are so many dynamics involved, the RS doesn't make sense for the current SS so there must be another reason. He hasn't done anything like this over the past 3 years but could have, so why now? That is the question I ask myself. Is there something more to it that us average joe/jane investors don't see or know?

Just my opinion and take on things. It doesn't make sense and yes, he did make a mistake and screwed up on the initial 8k filing.

GLTU, all IMHO.

D

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.